HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting.

@article{Marinone2011HBVDH,
  title={HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting.},
  author={Carlo Marinone and Monica Mestriner},
  journal={Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver},
  year={2011},
  volume={43 Suppl 1},
  pages={S49-56}
}
HBV reactivation in patients with haematological malignancies undergoing chemoimmunotherapy is a serious and frequent complication. This is linked to either the high frequency of inactive HbsAg carriers and occult B infection among oncohaematological patients or the profound immunosuppression caused by high dose chemotherapy, monoclonal antibody therapy or auto- and allo-haematopoietic stem cell (HSC) transplantations. Identifying the patients at risk is mandatory in this clinical setting and… CONTINUE READING